CALITHERA BIOSCIENCES INC's ticker is CALA and the CUSIP is 13089P101. A total of 78 filers reported holding CALITHERA BIOSCIENCES INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $192,000 | -50.6% | 79,200 | 0.0% | 0.00% | – |
Q4 2020 | $389,000 | +42.5% | 79,200 | 0.0% | 0.00% | – |
Q3 2020 | $273,000 | -34.7% | 79,200 | 0.0% | 0.00% | – |
Q2 2020 | $418,000 | +56.0% | 79,200 | +31.3% | 0.00% | – |
Q1 2020 | $268,000 | +1.5% | 60,300 | +30.2% | 0.00% | – |
Q4 2019 | $264,000 | +84.6% | 46,300 | 0.0% | 0.00% | – |
Q3 2019 | $143,000 | -21.0% | 46,300 | 0.0% | 0.00% | – |
Q2 2019 | $181,000 | -11.7% | 46,300 | +52.3% | 0.00% | – |
Q1 2019 | $205,000 | +68.0% | 30,400 | 0.0% | 0.00% | – |
Q4 2018 | $122,000 | -23.8% | 30,400 | 0.0% | 0.00% | – |
Q3 2018 | $160,000 | +5.3% | 30,400 | 0.0% | 0.00% | – |
Q2 2018 | $152,000 | -14.6% | 30,400 | +7.4% | 0.00% | – |
Q1 2018 | $178,000 | -24.6% | 28,300 | 0.0% | 0.00% | – |
Q4 2017 | $236,000 | -33.7% | 28,300 | +25.2% | 0.00% | – |
Q3 2017 | $356,000 | -60.4% | 22,600 | -62.7% | 0.00% | -100.0% |
Q2 2017 | $899,000 | +1241.8% | 60,520 | +1376.1% | 0.00% | – |
Q1 2015 | $67,000 | – | 4,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Delphi Management Partners VIII, L.L.C. | 2,426,702 | $5,072,000 | 4.00% |
BVF INC/IL | 7,299,331 | $15,256,000 | 0.57% |
TSP Capital Management Group, LLC | 463,500 | $969,000 | 0.32% |
Tibra Equities Europe Ltd | 158,500 | $331,000 | 0.10% |
Parkman Healthcare Partners LLC | 100,628 | $210,000 | 0.05% |
SILVERARC CAPITAL MANAGEMENT, LLC | 31,382 | $66,000 | 0.03% |
FEDERATED HERMES, INC. | 6,668,978 | $13,938,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 108,111 | $226,000 | 0.02% |
FRANKLIN STREET ADVISORS INC /NC | 133,580 | $279,000 | 0.02% |
XTX Topco Ltd | 31,242 | $65,000 | 0.02% |